2m 2m 2m 2m 2m 2m 2m
RELMADA THERAPEU (RLMD)
NASDAQ
$6.47+$0.01 (+0.23%)
Price as of Jul 14, 2026 5:29 AM EDT- $677.2MMarket Cap
- 927.89%1-Year Change
- BiotechnologyIndustry
RELMADA THERAPEU (RLMD)
$6.47+$0.01 (+0.23%)
RLMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.45 | ||
Change | +$0.04 (+0.62%) | ||
Open | $6.38 | ||
High | $6.51 | ||
Low | $6.28 | ||
Previous Close | $6.41 | ||
Volume | 2,145,431 | ||
30-Day Average Volume | 2,729,094 | ||
1-Week Change | 1.90% | ||
1-Month Change | -3.01% | ||
1-Year Change | 927.89% | ||
3-Year Change | 128.72% | ||
5-Year Change | -80.74% | ||
Fundamentals | |||
Shares Outstanding | 105.0M | ||
Total Assets | $235.4M | ||
Market Cap | $677.2M | ||
Enterprise Value | $667.4M | ||
Period: QTR TTM FY | |||
Revenue | -$549,964.00 | ||
Net Income | -$19.1M | ||
Free Cash Flow | -$15.1M | ||
EBIT | -$19.1M | ||
EBITDA | -$19.1M | ||
Net Working Capital | $222.5M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | -35 | ||
Enterprise Value/Revenue | -1,214 | ||
P/B | 3 | ||
P/E | -29 | ||
PEG | -1 | ||
Price/Free Cash Flow | -45 | ||
Price/Operating Cash Flow | -45 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 09/30/2019 | ||
Earnings & Revenue